14-day Premium Trial Subscription Try For FreeTry Free
$3.52
-0.96 (-21.43%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Mar 07, 2024 Buy 205 008 Levine James E. Stock Options
Mar 07, 2024 Buy 205 008 Kabbinavar Fairooz Stock Options
Mar 07, 2024 Buy 205 008 Smeal Tod Stock Options
Mar 07, 2024 Buy 510 000 Erlander Mark Stock Options
Dec 19, 2023 Buy 30 000 Pace Gary W Common Stock
Nov 10, 2023 Buy 22 950 Pace Gary W Common Stock
Jun 15, 2023 Buy 27 700 Markin Rodney S Stock Options
Jun 15, 2023 Buy 27 700 Armitage James O Stock Options
Jun 15, 2023 Buy 27 700 White Lale Stock Options
Jun 15, 2023 Buy 27 700 Pace Gary W Stock Options
Jun 15, 2023 Buy 27 700 Mohindru Mani Stock Options
Jun 15, 2023 Buy 27 700 Tannenbaum Renee P Stock Options
Mar 15, 2023 Buy 167 088 Smeal Tod Stock Options
Mar 15, 2023 Buy 197 472 Levine James E. Stock Options
Mar 15, 2023 Buy 125 520 Kelemen Vicki Stock Options
Mar 15, 2023 Buy 482 064 Erlander Mark Stock Options
Jan 30, 2023 Buy 425 000 Kabbinavar Fairooz Stock Options
Nov 25, 2022 Buy 10 000 Erlander Mark Common Stock
Sep 19, 2022 Buy 15 000 White Lale Common Stock
Sep 16, 2022 Buy 13 000 Armitage James O Common Stock
Sep 16, 2022 Buy 30 000 Levine James E. Common Stock
Sep 15, 2022 Buy 3 600 Tannenbaum Renee P Common Stock
Sep 15, 2022 Buy 6 400 Tannenbaum Renee P Common Stock
Sep 15, 2022 Buy 150 000 Pace Gary W Common Stock
Jul 05, 2022 Buy 28 858 White Lale Common Stock
Jun 09, 2022 Buy 530 Brancaccio John P Stock Options
Jun 09, 2022 Buy 223 Brancaccio John P Stock Options
Jun 09, 2022 Buy 223 Brancaccio John P Stock Options
Jun 09, 2022 Buy 195 Brancaccio John P Stock Options
Jun 09, 2022 Buy 22 000 Brancaccio John P Stock Options
Jun 09, 2022 Buy 26 800 Brancaccio John P Stock Options
Jun 09, 2022 Buy 22 000 Brancaccio John P Stock Options
Jun 09, 2022 Buy 28 858 Brancaccio John P Stock Options
Jun 09, 2022 Buy 44 734 Brancaccio John P Stock Options
Jun 09, 2022 Buy 755 Brancaccio John P Stock Options
Mar 09, 2022 Buy 26 800 Pace Gary W Stock Options
Mar 09, 2022 Buy 26 800 Pace Gary W Stock Options
Mar 09, 2022 Buy 26 800 White Lale Stock Options
Mar 09, 2022 Buy 26 800 Tannenbaum Renee P Stock Options
Mar 09, 2022 Buy 26 800 Tannenbaum Renee P Stock Options
Mar 09, 2022 Buy 170 016 Ruffner Katherine L Stock Options
Mar 09, 2022 Buy 26 800 Mohindru Mani Stock Options
Mar 09, 2022 Buy 26 800 Mohindru Mani Stock Options
Mar 09, 2022 Buy 26 800 Markin Rodney S Stock Options
Mar 09, 2022 Buy 26 800 Markin Rodney S Stock Options
Mar 09, 2022 Buy 170 016 Levine James E. Stock Options
Mar 09, 2022 Buy 170 016 Kelemen Vicki Stock Options
Mar 09, 2022 Buy 170 016 Kelemen Vicki Stock Options
Mar 09, 2022 Buy 370 128 Erlander Mark Stock Options
Mar 09, 2022 Buy 370 128 Erlander Mark Stock Options
Mar 09, 2022 Buy 26 800 Brancaccio John P Stock Options
Mar 09, 2022 Buy 26 800 Brancaccio John P Stock Options
Mar 09, 2022 Buy 26 800 Armitage James O Stock Options
Jan 10, 2022 Buy 275 088 Smeal Tod Stock Options
Sep 21, 2021 Buy 30 000 Pace Gary W Common Stock
Sep 10, 2021 Buy 5 000 Levine James E. Common Stock
Sep 10, 2021 Buy 5 000 Levine James E. Common Stock
Sep 10, 2021 Buy 10 000 Levine James E. Common Stock
Sep 10, 2021 Buy 5 000 Levine James E. Common Stock
Sep 10, 2021 Buy 5 000 Levine James E. Common Stock
Jul 12, 2021 Buy 200 000 Ruffner Katherine L Stock Options
Jul 12, 2021 Buy 390 000 Levine James E. Common Stock
Jul 12, 2021 Buy 0 Levine James E.
Jul 06, 2021 Buy 0 Ruffner Katherine L
Jun 10, 2021 Buy 28 858 Jacob Gary S Stock Options
Jun 10, 2021 Buy 293 Jacob Gary S Stock Options
Jun 10, 2021 Buy 218 Jacob Gary S Stock Options
Jun 10, 2021 Buy 223 Jacob Gary S Stock Options
Jun 10, 2021 Buy 223 Jacob Gary S Stock Options
Jun 10, 2021 Buy 530 Jacob Gary S Stock Options
Jun 10, 2021 Buy 755 Jacob Gary S Stock Options
Jun 10, 2021 Buy 44 734 Jacob Gary S Stock Options
Jun 10, 2021 Buy 22 000 White Lale Stock Options
Jun 10, 2021 Buy 44 001 Tannenbaum Renee P Stock Options
Jun 10, 2021 Buy 22 000 Pace Gary W Stock Options
Jun 10, 2021 Buy 44 001 Mohindru Mani Stock Options
Jun 10, 2021 Buy 22 000 Markin Rodney S Stock Options
Jun 10, 2021 Buy 200 928 Kelemen Vicki Stock Options
Jun 10, 2021 Buy 435 072 Erlander Mark Stock Options
Jun 10, 2021 Buy 22 000 Brancaccio John P Stock Options
Jun 10, 2021 Buy 22 000 Armitage James O Stock Options
Jun 10, 2021 Buy 298 320 Adams Thomas Phd Stock Options
Jun 10, 2021 Buy 272 Adams Thomas Phd Stock Options
Jun 10, 2021 Buy 223 Adams Thomas Phd Stock Options
Jun 10, 2021 Buy 223 Adams Thomas Phd Stock Options
Jun 10, 2021 Buy 530 Adams Thomas Phd Stock Options
Jun 10, 2021 Buy 755 Adams Thomas Phd Stock Options
Jun 10, 2021 Buy 173 145 Adams Thomas Phd Stock Options
Jun 10, 2021 Buy 0 Tannenbaum Renee P
Jun 10, 2021 Buy 0 Mohindru Mani
Mar 26, 2021 Buy 2 900 Markin Rodney S Common Stock
Mar 23, 2021 Buy 2 500 Pace Gary W Common Stock
Mar 23, 2021 Buy 2 500 Pace Gary W Common Stock
Mar 23, 2021 Buy 5 000 Pace Gary W Common Stock
Mar 23, 2021 Buy 470 Jacob Gary S Common Stock
Mar 23, 2021 Buy 1 900 Jacob Gary S Common Stock
Mar 23, 2021 Buy 960 Kelemen Vicki Common Stock
Mar 23, 2021 Buy 965 Erlander Mark Common Stock
Mar 22, 2021 Buy 3 000 Brancaccio John P Common Stock
Mar 19, 2021 Buy 4 000 Armitage James O Common Stock
JSON CSV
INSIDER POWER
92.115
Last 100 transactions
Buy: 7 219 001 | Sell: 0 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 92.115.

In total, the insiders bought 7 219 001 and sold 0 CRDF shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Cardiff Oncology Inc.

Cardiff Oncology. Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevac... CRDF Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT